The Xpect Digestive Test Kit is a rapid, qualitative immunoassay designed for the simultaneous detection of Giardia lamblia and Cryptosporidium parvum antigens in human fecal specimens. This non-waived test under the Clinical Laboratory Improvement Amendments (CLIA) is a crucial tool for clinical laboratories, healthcare providers, and diagnostic centers focused on the prompt diagnosis of these common enteric pathogens.
Technical Specifications:
Common Applications and User Groups:
- Clinical Laboratories: Providing rapid results for patient management
- Hospitals: Emergency and pediatric departments for quick screening
- Travel Medicine: Testing for travelers returning with gastrointestinal symptoms
- Public Health: Outbreak investigation and surveillance
- Rural and Remote Clinics: Where access to full laboratory services may be limited
Supplier Overview:
Remel, a part of Thermo Fisher Scientific, is a leading provider of microbiology solutions, including diagnostic kits, culture media, and reagents. With a commitment to innovation and quality, Remel has established itself as an authority in the field of diagnostic microbiology. Their extensive experience and dedication to improving public health through accurate and accessible diagnostics make them a trusted supplier for the Xpect Digestive Test Kit Giardia Cryptosporidium CLIA Non-Waived. Their products are backed by rigorous research and development, ensuring that healthcare professionals have access to reliable and efficient diagnostic tools.